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Abstract    
Gene expression is a multi-step process which proceeds from DNA through 
RNA to protein. The tight regulation of this process is essential for overall cellular 
integrity and physiological homeostasis. Regulation of the messenger RNA 
(mRNA) levels has emerged as a crucial event in the modulation of the expression 
of genetic information. The mechanisms by which this process occurs have been 
extensively studied and begin to be much better understood. They involve a net-
work of complex pathways that use intrinsic features of the target mRNA, like 
stability, to control its relative abundance in the cytoplasm. Thus, the analysis of 
the mRNA stability and abundance is essential to properly undertake gene expres-
sion studies. This chapter describes the ribonuclease protection assay, a widely ac-
cepted approach to evaluate the quality and amount of a target mRNA. This tech-
nique displays a higher sensitivity than classical Northern blot analysis and may 
be used either individually or in combination with other quantitative methods, 
such as quantitative reverse-transcription PCR (qRT-PCR), as complementary 




Gene expression control is a key point for cell development and survival across 
all living kingdoms, from bacteria to mammals. Since RNA molecules are the cen-
tral effectors of the genetic information flow, the precise regulation of their rela-
tive abundance and stability is essential for the proper synthesis, assembly and lo-
calization of subcellular structures (1, 2). Regulation of the RNA levels is a multi-
step process that requires an accurate coordination between all the cellular proc-
esses. In eukaryotes, it begins in the nucleus, where protein factors specifically 
bind to DNA sequences activating or inhibiting the RNA synthesis. Nascent tran-
scripts recruit diverse proteins that mediate multiple RNA modifications such as 
splicing, 5’-capping, 3’-polyadenilation and editing. Mature molecules are subse-
quently exported to the cytoplasm and directed to macromolecular complexes 
where they play essential roles in protein synthesis (rRNAs, mRNAs; (1)) and 
mRNA post-transcriptional regulation (miRNAs; (3, 4)), among others. RNA 
molecules are eventually eliminated following diverse degradation pathways (5-
7). In consequence, gene expression studies inevitably require the evaluation of 
the quality, stability and relative abundance of the intracellular RNA transcripts.  
This chapter focuses on a classical strategy for the analysis of specific 
transcripts, the ribonuclease protection assay (RPA). It constitutes a very reliable 
and sensitive method for detection, quantification and analysis of RNA species in 
complex mixtures of total cellular RNA (8-11). RPA is based on the ribonucleases 
(RNases) ability to specifically discriminate between double and single stranded 
RNA templates. In this approach, RNA transcripts are hybridized in solution with 
a radioactive labelled RNA probe that is complementary to the molecule under in-
vestigation (Fig. 1). This interaction is performed under highly stringent condi-
tions that are usually assessed by adding formamide to the hybridization buffer, 
which considerably reduces non-specific interactions. After hybridization, subse-
quent nuclease treatment removes non-interacting molecules. Several RNases spe-
cific for single-stranded RNA such as RNase T1 or RNase A can be used, either 
individually or in combination. Thus, non-hybridized RNA molecules or mis-
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matched RNA duplexes are degraded, while intact fully matched probe:transcript 
duplexes can be recovered by ethanol precipitation and resolved in denaturing 
polyacrylamide gels. With this technique, the size, amount and integrity of the de-
sired RNA can be interrogated by subsequent exposure to autoradiography film or 
phosphoimaging (Fig. 2). Ideally, when this procedure is carried out with a molar 
excess of the probe over the target RNA, the intensity of the signal from the pro-
tected fragment is proportional to the amount of complementary RNA in the sam-
ple.  
RPA is a widely accepted technique which complements the information 
obtained from qRT-PCR, with the advantage that it does not require a reverse 
transcription step. In addition, it provides additional data that cannot be obtained 
from qRT-PCR, like the size and integrity of a specific transcript. It may also sub-
stitute the Northern blotting analysis, in which the sensitivity, specificity and reso-
lution limitations are often compromised by the inability to load large RNA 
amounts in the gel, inefficient transfer from gel to the blot membrane and cross or 
non-specific hybridization between probes and target RNA molecules. In addition, 
the hybridization in solution in the RPA favours the detection of rare transcripts. 
Furthermore, RPA replaces other classical nuclease-based methods, such as the S1 
nuclease analysis, which usually employs DNA probes that are synthesized as 
double-stranded molecules. This entails that reconstitution of probe duplexes is 
probable, therefore reducing the sensitivity. Hence, careful purification of the 
probe strand is a requisite for a proper analysis.  
RPA assays are well suited for mapping positions of external and internal 
junctions in RNA, such as transcription initiation and termination sites and in-
tron/exon boundaries (12-14). With a proper probe design, RPA reveals the pres-
ence of sense and antisense transcripts from gene units (15) and allows for the es-
timation of genetic diversity in complex viral populations (16). It has been 
successfully used in the evaluation of the stability of therapeutic ribonucleoprotein 
complexes (17) and to quantify viral RNA replication levels (Fig. 2; (18)). RPA 
also allows to discriminate between closely related targets like members of a mul-
tigene family, by using probes designed to span the differing regions (19). These 
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reactions can also be performed as multiplex assays to simultaneously analyze 
several transcripts (20), as long as the protected fragments exhibit different sizes. 
Moreover, its high sensitivity and specificity have been exploited for detection and 
quantification of microRNAs (miRNAs; (21)). Recently, modifications in the RPA 
technique have been reported to provide exclusive data that cannot be supplied by 
other methodologies. For instance, a sequential RPA/primer extension analysis has 
been described to distinguish among paralogous miRNAs that differ from each 
other by only one nucleotide located at their 5′ end (22).  
In summary, RPA is a reproducible and independent method that pro-
vides significant and valuable information in gene expression studies. In this chap-
ter, we describe in detail the analysis of specific eukaryotic mRNAs by RPA 
analysis.  
2. MATERIALS 
All reagents and solutions, as well as plastic and glassware, must be free of ri-
bonucleases. Gloves must be worn at all the times.  
2.1. RNA isolation 
1. Denaturing solution (see Note 1): 4 M guanidinium thiocyanate; 25 mM so-
dium citrate, pH 7.0; 0.5 % (w/v) N-laurosylsarcosine (Sarkosyl); 0.1 M 2-
mercaptoethanol. 
2. Sodium acetate 2 M, pH 4.0. 
3. Water-saturated phenol. 
4. Chloroform:isoamyl alcohol (49:1, v/v) or bromochloropropane. 
5. Isopropanol. 
6. 80 % ethanol. 
7. RNase free sterile distilled water. 
8. Glass-Teflon homogenizer. 
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2.2. Probe synthesis 
1. DNA templates (plasmid DNA or PCR products). 
2. Restriction enzymes to digest the plasmid templates to define the proper 3' 
end of the RNA.  
3. NTP mix stock solution: 10 mM adenosine 5’ triphosphate (ATP), citosine 
5’ triphosphate (CTP) and guanosine 5’ triphosphate (GTP); 1 mM uridine 5’ 
triphosphate (UTP).  
4. Transcription buffer, made according to the manufacturer's instructions. A 
common recipe is 40 mM Tris-ClH, pH 8.0; 6 mM MgCl2; 1 mM spermidine; 4 
mM NaCl; 10 mM dithiothreitol; 0.01 % Triton X-100 .  
5. [α-32P-UTP], 10 mCi/ml, 800 Ci/mmol. It is recommended to be used within 
14 days of the labelling date to ensure high specific activity. It is a hazardous ma-
terial, appropriate protection is required when handling. 
6. Placental ribonuclease inhibitor (40 U/μl). 
7. T7 RNA polymerase. 
8. RNase-free DNase I (1-10 U/μl; e.g., RQ1 DNase from Promega). 
9. 40 % polyacrylamide stock solution (19:1 acrylamide:bis-acrylamide). 
10. 10X TBE buffer: 0.89 M Tris base; 0.89 M boric acid; 25 mM ethyl-
enediamine-tetraacetic acid (EDTA). 
11. Ammonium persulfate (APS) 10 % (w/v). 
12. N, N, N’, N’-tetramethyl-ethylene diamine (TEMED). 
13. Formamide loading buffer: 97 % formamide deionized ultrapure grade; 17 
mM EDTA; 0.025 % xylene cyanol; 0.025 bromophenol blue.   
14. RNA elution buffer: 0.5 M ammonium acetate; 0.1% sodium dodecyl sul-
phate (SDS); 1 mM EDTA. 
15. Buffered saturated phenol. 
16. Chloroform:isopropyl alcohol (24:1). 
17. Sodium acetate 3M, pH 5.2 and pH 6. 
18. 100 % ethanol. 
19. RNase free sterile distilled water. 
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20. Sterile razor blades. 
2.3. Ribonuclease protection assay 
1. Hybridization buffer: 80 % deionized formamide; 40 mM PIPES, pH 6.4; 
400 mM NaCl; 1 mM EDTA. 
2. Ribonuclease digestion buffer: 300 mM NaCl; 10 mM Tris–HCl, pH 7.4; 5 
mM EDTA; 10 U RNase T1; 40 µg/ml RNase A. 
3. SDS 20 % (w/v). 
4. Proteinase K, 20 mg/ml. 
5. tRNA, 10 μg. 
6. Buffered saturated phenol. 
7. Chloroform:isopropyl alcohol (24:1). 
8. Sodium acetate 3 M, pH 5.2 and pH 6. 
9. 100 % ethanol. 
10. Formamide loading buffer. 
11. 40 % polyacrylamide stock solution (19:1 acrylamide:bis-acrylamide). 
12. TBE buffer. 
11. APS 10 % (w/v). 
12. TEMED. 
12. RNase free sterile distilled water. 
3. METHODS 
3.1. Total cellular RNA extraction 
The isolation of clean intact RNA is essential for the RPA. Procedures devel-
oped for extracting RNA from cultured cells involve complete cell lysis that liber-
ates all the nucleic acids from different organelles. This involves that DNA and 
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RNA are co-purified in the initial steps. Additional treatments are then required to 
remove the DNA. Other difficulty in RNA isolation is the contamination with in-
tra- and extracellular ribonucleases, which are very stable and remain active under 
very suboptimal conditions. Hence, cell lysis in a chemical environment that inac-
tivates nucleases is indispensable. Subsequent treatments allow for the selective 
purification of RNA from other macromolecular complexes. 
There are several methods for preparing RNA from eukaryotic cells. 
Most of them employ common laboratory reagents, but commercial kits are also 
available. Here, we present a widely used protocol for total RNA extraction from 
adherent and suspension culture cells, the so-called guanidinium thiocyanate-
phenol-chloroform extraction method (23). It is based on the potent protein dena-
turing properties of the guanidinium thiocyanate. This chaotropic compound had 
been traditionally used as ribonuclease inhibitor by other authors in RNA extrac-
tion procedures (24, 25), but these required several ultracentrifugation steps to 
completely remove genomic DNA. This was notably time-consuming and limited 
the number of samples to be processed. The discovery that only total RNA re-
mained soluble in the acidic aqueous phase after treatment with acid guanidinium 
thiocyanate-phenol-chloroform prompted the optimization of a faster purification 
protocol. The guanidinium thiocyanate-phenol-chloroform extraction method ren-
ders high yield of RNA from a small amount of start sample (tissue, cell culture), 
retrieves a good representation of the intracellular RNA pool and can be easily 
scaled up. The development of a single-step protocol was an important advance in 
the field and led to the marketing of kits that reduce hazardous handling and time 
for reagents preparation (RNAzol from MRC, TRI Reagent from Sigma-Aldrich 
or Trizol from Invitrogen-Life Technologies). The standard protocol for total 
RNA extraction is detailed below. 
1. Homogenization: 
For tissues: add 1 ml of denaturing solution to 100 mg of fresh tissue. Ho-
mogenize in a glass-Teflon homogenizer with a few strokes.  
For culture cells: discard cell culture medium either by centrifugation (in case 
of cells growing in suspension) or by removing it from adherent cells. Wash cells 
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twice in PBS. Then, add 1 ml of denaturing solution per 107 cells and mix by pi-
petting, which favours cell lysis and DNA fragmentation.  
Samples must not remain in denaturing buffer for more than 30 min. 
2. Transfer the homogenate to a polypropylene tube. 
3. Add 0.1 volumes of sodium acetate 2 M pH 4.0 and mix thoroughly by in-
verting the tube. 
4. One volume of water-saturated phenol is then supplied and mixed by inver-
sion (see Note 2). 
5. Extraction is completed by the addition of 0.2 volumes of chloro-
form:isoamyl alcohol (49:1) solution or bromochloropropane and vigorous shak-
ing during 15 sec. This aids the dissociation of the nucleoprotein complexes. 
6. Preserve the samples at room temperature during 3 min. 
7. Centrifugate 20 min at 10000 x g, 4 ºC.  
8. The aqueous upper phase mostly containing the cellular RNA pool is care-
fully transferred to a new tube. RNA is then precipitated by adding one volume of 
100 % isopropanol and incubation at room temperature for 10 min (see Note 3). 
Centrifugate the samples at 10000 x g during 20 min to pellet total RNA. It should 
appear as a gel-like precipitate. 
9. Resuspend the precipitate in 1 ml of ethanol 80 % and vortex it to wash away 
the residual guanidinium. Incubate 10 min at room temperature. 
10. Centrifugate 10 min at 10000 x g, 4 ºC. Discard the supernatant and air-dry 
the pellet.  
11. Dissolve the RNA pellet in hybridization buffer by briefly vortexing or by 
heating at 60 ºC during 5 min. 
12. Spectrophotometric readings at wavelengths of 260 and 280 nm (A260, 
A280), respectively, are required to analyze the RNA amount and the quality of the 
preparation. Measurements at 260 nm allow for the calculation of nucleic acid 
concentration, whereas the ratio A260/A280 estimates the contamination with phenol 
or proteins. This value should be between 1.8-2 in pure preparations. 
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3.2. Synthesis and purification of the RNA probes 
A DNA construct must be designed and produced for each specific RNA probe. 
The minimal requirement is a double-stranded promoter sequence upstream of the 
template for the desired RNA. The most common approach is the use of plasmid 
vectors carrying the T7 RNA polymerase promoter upstream of a multicloning site 
where the specific template sequences can be inserted. Alternatively, the use of 
PCR products as DNA templates carrying the T7 promoter sequence at their 5’ 
end is also possible (see Note 4). Recommended probe size is 200 to 400 base 
pairs, though shorter probes may be used for abundant targets. Nevertheless, probe 
size is determined by the molecular feature to be sought. In any case, a careful re-
moval of the DNA template must be accomplished to avoid the formation of het-
eroduplexes DNA template:RNA probe, which could promote misleading results. 
Probe gel purification is generally recommended, since incomplete transcripts may 
increase background levels and lost of sensitivity.   
1. DNA template preparation: 
For plasmid constructs:  
Digest the plasmid containing the probe coding sequence with a restric-
tion enzyme that cuts at the 3’ end of the probe coding sequence. This provides a 
proper template for the RNA synthesis (Note 5). 
For PCR templates: 
Amplify the sequence of interest by PCR using a 5’ primer containing the 
T7 RNA polymerase promoter sequence.  
2. Check the quality of the template by agarose electrophoresis.  
3. Extract DNA by adding an equal volume of buffered-saturated phenol. Mix 
well to form an emulsion and centrifugate for 2 min at 12000 x g.  
4. Transfer the aqueous upper phase to a new tube and add one volume of chlo-
roform:isoamyl alcohol (24:1). Mix by vortexing and centrifugate again.   
5. Keep the upper phase and add 0.1 volume of 3 M sodium acetate pH 6 along 
with three volumes of cold (-20 ºC) absolute ethanol.  
6. Incubate at -20 ºC for 30 min and centrifugate for 30 min at 12000 x g, 4 ºC.  
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7. Discard the supernatant and wash the pellet with 300 μl of 70 % ethanol.  
8. Centrifugate for 5 min at 12000 x g, 4 ºC.  
9. Remove the supernatant and vacuum-dry briefly the DNA pellet.  
10. Dissolve the template in RNase free sterile distilled water. 
11. Set up 50 μl transcription reactions in transcription buffer 1X containing 1 
μg of purified DNA template, 5 μCi of [α-32P]UTP (3000 Ci/mmol), 1 mM GTP, 
1 mM ATP, 1 mM CTP, 0.1 mM UTP (to achieve high specific activity of the 
RNA probe; Note 6), 0.5 U/μl of placental ribonuclease inhibitor and 20 μg/ml of 
purified T7 RNA polymerase.  
12. Incubate the reaction mix at 37 ºC for 2 h. 
13. Stop the reaction by adding 1 U of RNase-free DNase and incubate at 37 ºC 
for 15 min. 
14. An equal volume of formamide loading buffer (50 μl) is added and samples 
are heated at 95 ºC in a dry bath before loading directly on preparative denaturing 
polyacrylamide-7 M urea gels. The gel concentration should be chosen according 
to the size of the RNA molecule to be purified (3.5 % - 20 %). Electrophoresis 
should be performed under denaturing conditions in TBE 0.5X.  
15. Cover the gel with a saran-wrap and place it on an exposure cassette with a 
sheet of X-ray film. Expose it in a dark room (see Note 7). The acrylamide slice 
containing the full-length probe is excised using a razor blade. 
16. The gel slices are then soaked in 300 μl of RNA elution buffer and incu-
bated overnight at 4 ºC.  
17. Purify the RNA by consecutive phenol and chloroform:isoamyl alcohol ex-
traction as indicated in steps 3-5. 
18. Precipitate the RNA by adding 0.1 volume of 3 M sodium acetate pH 5.2 
and three volumes of cold (-20 ºC) absolute ethanol.  
19. Pellet the RNA as noted in steps 6-9. 
20. Dissolve the labelled RNA in hybridization buffer.  
21. Check the specific activity of the probe in a scintillation counter. The prod-
uct should be stored at – 20 ºC until use. 
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3.3. Ribonuclease protection assay 
1. Mix 10 μg of total cellular RNA with 105 cpm of RNA probe in 30 μl of hy-
bridization buffer (see Note 8). Include a negative control with tRNA instead of 
total RNA. This provides information about the background hybridization and the 
yield of the ribonuclease digestion reaction (see Note 9).  
2. Denature RNA by heating at 85 ºC during 5 min. 
3. Immediately transfer the mix to the hybridization temperature (see Note 10). 
4. Anneal overnight. 
5. Add 300 μl of RNase digestion buffer and incubate at 30 ºC for 30 to 60 min. 
6. Stop the reaction by the addition of SDS 1 % and 10 mg/ml of proteinase K. 
Incubate 30 min at 37 ºC. 
7. Undigested RNA is extracted with phenol:chloroform:isoamyl alcohol and 
precipitated with ethanol as described above. 
8. Dry pellets are resuspended in formamide loading buffer and resolved by de-
naturing polyacrylamide-urea gels. 
3.4. Analysis 
Gels are exposed to autoradiography film or phosphoimaging and subsequently 
analyzed and quantified by densitometric or fluorescence scanning.  
One of the main RPA applications is the absolute quantification of a specific 
RNA. For that purpose, a standard curve must be established using known 
amounts of the in vitro transcribed target hybridized with an excess of the probe. 
After ribonuclease treatment, products are resolved in denaturing polyacrylamide 
gels. The intensity of the signal is compared to that generated by the experimental 
samples and used to determine the absolute amount of target RNA. 
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4. NOTES 
1. Prepare a 7 M guanidinium thiocyanate stock solution in RNase free sterile 
distilled water by heating at 65 °C. Then, add sodium citrate (pH 7.0) to reach a 
final concentration of 45 mM and 26.4 ml of 10 % (w/v) Sarkosyl (N-
laurosylsarcosine). The stock solution can be stored up to 3 months at room tem-
perature. To prepare the working denaturing solution, just add 2-mercaptoethanol 
(0.5 % final concentration). This solution can be stored up for 1 month at room 
temperature. To minimize handling of guanidinium thiocyanate, dissolve it di-
rectly in the manufacturer's bottle. The 2-mercaptoethanol should be handled un-
der a fume hood. 
2. Preservation of the acidic pH is a key factor in the success of the RNA isola-
tion method. A low pH value ensures the proper separation of RNA from DNA 
and proteins. For this reason, it is recommended the use of water-saturated phenol 
instead of buffered-saturated phenol.  
3. RNA precipitation can be improved by increasing the incubation time up to 1 
h. In this case, samples should be maintained at -20 ºC. This is specially recom-
mended when working with low amount of starting material. 
4. T7 RNA polymerase efficiently synthesizes RNA molecules in vitro with 
minimal requirements. These include the 17 nt double-stranded promoter sequence 
followed by GGG and a single-stranded template.  
 
5’ - TAATACGACTCACTATA↓GGG 
3’ - ATTATGCTGAGTGATAT  CCCXXXX……….XXX - 5’ 
 
Structure of the partially double-stranded DNA template. 
T7 promoter sequence is shown in bold; ↓ indicates the transcription initiation 
site. 
5. The enzyme may cut the plasmid in multiple positions, as long as it does not 
cut into the promoter or the probe sequence. Complete digestion of the plasmid 
template should be checked by agarose electrophoresis. The presence of non-
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digested molecules in the reaction results in run on transcripts that use up nucleo-
tides and reduce the yield of the probe synthesis. 
6. This is a general protocol that must be optimized for each specific probe. 
The nucleotide concentration is especially relevant: the lower amount of nucleo-
tide, the higher proportion of incomplete transcripts. For short RNA probes (less 
than 400 nt), 1 mM of each non-labelled NTP generally renders high transcription 
yields. Long probes require specific transcription buffers with higher amounts of 
nucleotides and divalent cations. In many cases, it may be necessary the addition 
of non-radioactive limiting nucleotides to preserve the nucleotide concentration 
high enough to produce significant amounts of full-length transcript. This leads to 
a decreased specific activity that will be compensated by the increased sensitivity 
of the longer probe. Alternatively, commercial kits are currently available that 
produce high amounts of long RNA molecules (up to 3000 nt).  
7. The position of the film on the gel is recorded using a marker, with non-
symmetric lines drawn across all edges of the film to ensure its correct reposition-
ing on top of the gel after development. Alternatively, a variety of phosphorescent 
labels or markers available from different commercial sources can be used to 
guarantee the correct alignment of the film on the gel. A 2-5 minutes exposure 
should be enough for efficient transcription when using nucleotides with high spe-
cific activity. 
8. For total cellular RNA, 10 μg is enough to detect most of RNA molecules. 
However, this amount can be increased for low abundant species. 
9. Background hybridization is commonly due to incomplete digestion of the 
DNA template after the probe transcription reaction. Residual DNA template 
molecules can efficiently interact with the probe, leading to heteroduplexes 
DNA:RNA that are not cleaved by ribonucleases. Background can be also caused 
by the presence of trace amounts of non-digested single-stranded probe. In both 
cases, this generates smears that appear in all the reactions. A tRNA negative con-
trol allows for the evaluation of the background.  
10. There is an optimal annealing temperature for each probe, which depends 
not only on its sequence but also on its secondary structure. It is therefore advis-
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able to experimentally test the optimal temperature by using a range from 30 ºC to 
60 ºC. 
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FIGURE LEGENDS 
Fig. 1 Cartoon describing the ribonuclease protection assay (RPA). Purified 
RNA samples are hybridized in solution with a molar excess of a radioactive la-
belled RNA probe to generate RNA duplexes. Unpaired RNA molecules are di-
gested by the ribonuclease cocktail and protected fragments are resolved in dena-
turing polyacrylamide gels. These are subsequently exposed to evaluate the size 
and amount of the RNA under investigation  
 
Fig. 2 Representative ribonuclease probing assay (RPA) for relative quantifica-
tion of viral RNA. A human derived hepatoma cell line containing a replicon sys-
tem for the hepatitis C virus (HCV) was transfected with different amounts of the 
16  
HCV RNA domain SLIIIe+f. Total cellular RNA was hybridized overnight with 
10000 cpm of a sense RNA probe for the 5’ end of the HCV genome. After ribo-
nuclease digestion, products were resolved on 10 % denaturing polyacrylamide 
gels. Lane M denotes molecular weight marker. Figure is a kind gift of Dr. Saumi-
tra Das (18) by permission of Oxford University Press 
